女性血管造影试验的临床单位-猫眼课题宝

女性血管造影试验的临床单位

批准号：

2870004

负责人：

DAVID WATERS

金额：

$0.0万

依托单位：

HARTFORD HOSPITAL

依托单位国家：

美国

项目类别：

财政年份：

1996

资助国家：

美国

项目状态：

已结题

起止时间：

1996-08-30 至 2001-10-30

来源：

https://reporter.nih.gov/project-details/2870004

关键词：

angiography antioxidants atherosclerotic plaque cardiovascular disorder chemotherapy clinical research coronary disorder female hormone therapy human subject human therapy evaluation

项目摘要

项目成果

DAVID WATERS的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The purpose of this program is to assess whether hormonal replacement therapy and/or antioxidant treatment will stabilize or inhibit progression, and induce regression of coronary plaques in women. Phase 1(8 months) comprises planning and organizing the Study Protocols, Manual of Operations, and data forms. Protocol Development will take approximately 6 months. After Protocol Development, there will be an approximate 2 month hiatus in activity on the study. During this time, the participating centers will prepare and submit revised cost proposals based on the actual protocol. Phase 11(4 years) will be for patient recruitment and patient follow-up. Phase 111(6 months) is for data analysis.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文